ARCHIVES

In Brief: NCI Scientist Accused Of Taking ‘Payoffs’ Forom Drug Firms; GM-CS Wins FDA Approval

This article is from The Cancer Letter archive.

Vol. 17 No. 11 | March 15, 1991

Download PDF Visit The Full Archive

Related Articles

NIH Lifts Patient Limit On Gene Modified TIL Study; 6 Treated So Far

April 13, 1990

Fox Chase Symposium Tro Focus On Year 2000 Goals

August 21, 1987

Guest Editorial By Gregory Reaman: Memories Of A Merger Past

July 15, 2011

Moyniham Bill Will Direct HHS to Exempt Centers Recognized By NCI From Prospective Payment System

August 15, 1986

NIH Dedicates Louis Stokes Laboratories; Royston Retires As Kimmel Center President.

June 22, 2001

New Approach To Replacing Immune Cells Shrinks Tumors

September 27, 2002